Atherosclerotic renovascular disease in older dialysis patients

Rob Foley, Haifeng Guo, Philip A. Kalra

Research output: Contribution to journalArticlepeer-review


We hypothesized that atherosclerotic renovascular disease (ARVD) might account for a growing proportion of end-stage renal disease in the United States because of shared risk factors and the aging of the population. We tested this hypothesis through an evaluation of 146 973 older patients starting dialysis therapy in the United States between 1996 and 2001. The proportion with ARVD prior to dialysis therapy rose from 7.1% in 1996 to 11.2% in 2001. Geographic variations in diagnosis and therapeutic management of ARVD were noted. These results show that ARVD is rapidly emerging as a major cause of end-stage renal disease in the United States.

Original languageEnglish (US)
Pages (from-to)37-41
Number of pages5
JournalCardiology Review
Issue number10
StatePublished - Oct 1 2007


Dive into the research topics of 'Atherosclerotic renovascular disease in older dialysis patients'. Together they form a unique fingerprint.

Cite this